Author:
Nunoi Yoshio,Kambayashi Ryuichi,Goto Ai,Hagiwara-Nagasawa Mihoko,Chiba Koki,Izumi-Nakaseko Hiroko,Kawai Shinichi,Takei Yoshinori,Matsumoto Akio,Watanabe Yoshinori,Sugiyama Atsushi
Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference28 articles.
1. Katzung BG (2018) Vasodilators & the treatment of angina pectoris. In: Katzung BG (ed) Basic and clinical pharmacology, 14th edn. McGraw-Hill Education, New York, pp 194–211
2. Geng M, Lin A, Nguyen TP (2020) Revisiting antiarrhythmic drug therapy for atrial fibrillation: reviewing lessons learned and redefining therapeutic paradigms. Front Pharmacol 11:581837
3. Harvey RD, Grant AO (2018) Agents used in cardiac arrhythmias. In: Katzung BG (ed) Basic and clinical pharmacology, 14th edn. McGraw-Hill Education, New York, pp 228–253
4. Lei M, Wu L, Terrar DA, Huang CL (2018) Modernized classification of cardiac antiarrhythmic drugs. Circulation 138:1879–1896
5. Antzelevitch C, Belardinelli L, Zygmunt AC, Burashnikov A, Di Diego JM, Fish JM, Corderio JM, Thomas G (2004) Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 110:904–910